Login / Signup

CF 3 : an overlooked chromophore in VCD spectra. A review of recent applications in structural determination.

Sergio AbbateGiovanna LonghiGiuseppe MazzeoClaudio VillaniSilvija PetkovićRenzo Ruzziconi
Published in: RSC advances (2019)
The VCD spectra of several chiral compounds containing the CF 3 group are reviewed and analyzed. The list of compounds contains pharmaceutically relevant molecules as well as simple model molecules, having the value of case studies. In particular we point out the importance of the sign of the VCD band relative to some stretching normal mode of CF 3 in the region 1110-1150 cm -1 , as diagnostic of the configuration of stereogenic carbons C* to which the CF 3 group is bound: the correspondence (-) ↔ ( R ) and (+) ↔ ( S ) holds for 100% of 1-aryl-2,2,2-trifluoroethanols. DFT calculations confirm these conclusions, but for the rule established here they serve just as a check. This rule is tested on two new compounds, namely N-tert -butanesulfinyl-1-(quinoline-4-yl)-2,2,2-trifluoroethylamine, 8, and 4-[2-(2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile, 10, both containing two stereogenic elements, one of them being an asymmetric carbon C* of unknown configuration binding a CF 3 group. Discussion of the general validity of the rule is provided and some further tests are run on compounds in well-established drugs.
Keyphrases
  • cystic fibrosis
  • density functional theory
  • molecular dynamics simulations
  • capillary electrophoresis
  • tandem mass spectrometry